United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 6, 2026 · Filed May 7, 2026

On May 6, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$589.52 for US$5.6M under a trading plan, leaving 40,513 shares. Filed May 7, 2026 (Form 4).

Sold
9,500 shares
Price
US$589.52 average (US$576.32 to US$603.82)
Value
US$5.6M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 6, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 6, 2026Common StockSale80US$576.3249,933Direct
May 6, 2026Common StockSale120US$579.1249,813Direct
May 6, 2026Common StockSale384US$580.0749,429Direct
May 6, 2026Common StockSale296US$581.2849,133Direct
May 6, 2026Common StockSale159US$582.7348,974Direct
May 6, 2026Common StockSale796US$583.7348,178Direct
May 6, 2026Common StockSale873US$584.6447,305Direct
May 6, 2026Common StockSale927US$585.5346,378Direct
May 6, 2026Common StockSale805US$586.7845,573Direct
May 6, 2026Common StockSale470US$588.1945,103Direct
May 6, 2026Common StockSale410US$589.1844,693Direct
May 6, 2026Common StockSale320US$590.3644,373Direct
May 6, 2026Common StockSale101US$591.6044,272Direct
May 6, 2026Common StockSale80US$592.2744,192Direct
May 6, 2026Common StockSale346US$594.0943,846Direct
May 6, 2026Common StockSale1,513US$595.0242,333Direct
May 6, 2026Common StockSale560US$596.0541,773Direct
May 6, 2026Common StockSale680US$597.4741,093Direct
May 6, 2026Common StockSale460US$598.2140,633Direct
May 6, 2026Common StockSale80US$599.2640,553Direct
May 6, 2026Common StockSale40US$603.8240,513Direct

Source

View original at SEC

Related